NCT05803421 · Interventional trial
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Overall registry status Completed
Phase 3
Conditions Cardiovascular Diseases, Chronic Kidney Disease, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes
Delaware Valley sites
- Clinical Research of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory